ClearPoint Neuro, Inc. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: ClearPoint Neuro, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q2 2024.
ClearPoint Neuro, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$4.74M, a 33.5% increase year-over-year.
ClearPoint Neuro, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$18.6M, a 12% increase year-over-year.
ClearPoint Neuro, Inc. annual Operating Income (Loss) for 2023 was -$22.4M, a 37.4% decline from 2022.
ClearPoint Neuro, Inc. annual Operating Income (Loss) for 2022 was -$16.3M, a 22.1% decline from 2021.
ClearPoint Neuro, Inc. annual Operating Income (Loss) for 2021 was -$13.4M, a 115% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$18.6M	-$4.74M	+$2.39M	+33.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	-$21M	-$4.23M	+$1.48M	+25.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	-$22.4M	-$4.71M	-$237K	-5.3%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-12
Q3 2023	-$22.2M	-$4.9M	-$1.1M	-29%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	-$21.1M	-$7.13M	-$2.93M	-69.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	-$18.2M	-$5.71M	-$1.85M	-47.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	-$16.3M	-$4.47M	-$487K	-12.2%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-12
Q3 2022	-$15.8M	-$3.8M	+$9K	+0.24%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$15.9M	-$4.2M	-$797K	-23.4%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	-$15.1M	-$3.86M	-$1.68M	-77.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$13.4M	-$3.98M	-$1.72M	-75.9%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-01
Q3 2021	-$11.7M	-$3.8M	-$2.53M	-199%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	-$9.12M	-$3.41M	-$1.93M	-131%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021	-$7.19M	-$2.18M	-$972K	-80.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	-$6.22M	-$2.26M	-$846K	-59.6%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-09
Q3 2020	-$5.37M	-$1.27M	-$361K	-39.7%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$5.01M	-$1.48M	-$182K	-14.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$4.83M	-$1.21M	-$237K	-24.4%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	-$4.59M	-$1.42M	-$440K	-44.9%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-22
Q3 2019	-$4.15M	-$911K	+$296K	+24.5%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	-$4.45M	-$1.29M	+$343K	+21%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$4.79M	-$972K	+$455K	+31.9%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-13
Q4 2018	-$5.25M	-$979K	+$854K	+46.6%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-27
Q3 2018	-$6.1M	-$1.21M	+$121K	+9.13%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-13
Q2 2018	-$6.22M	-$1.64M	+$186K	+10.2%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-12
Q1 2018	-$6.41M	-$1.43M	-$73.5K	-5.43%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-13
Q4 2017	-$6.34M	-$1.83M	-$42.3K	-2.37%	Oct 1, 2017	Dec 31, 2017	10-K	2019-04-01
Q3 2017	-$6.29M	-$1.33M	+$382K	+22.4%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-13
Q2 2017	-$6.68M	-$1.82M	+$233K	+11.3%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	-$6.91M	-$1.35M	+$580K	+30%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	-$7.49M	-$1.79M	-$371K	-26.1%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-21
Q3 2016	-$7.12M	-$1.71M	+$217K	+11.3%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-06
Q2 2016	-$7.34M	-$2.06M	+$627K	+23.4%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-11
Q1 2016	-$7.96M	-$1.93M	+$1.01M	+34.3%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-09
Q4 2015	-$8.97M	-$1.42M	+$1.26M	+47%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-09
Q3 2015	-$10.2M	-$1.93M	+$691K	+26.4%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	-$10.9M	-$2.68M	-$467K	-21.1%	Apr 1, 2015	Jun 30, 2015	10-Q/A	2016-09-21
Q1 2015	-$10.5M	-$2.94M	-$5.14M	-234%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-06
Q4 2014	-$5.32M	-$2.68M	-$611K	-29.5%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-25
Q3 2014	-$4.71M	-$2.62M	-$757K	-40.7%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-13
Q2 2014	-$3.95M	-$2.22M	-$37.3K	-1.71%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-10
Q1 2014	-$3.92M	$2.19M	+$3.56M		Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-07
Q4 2013	-$7.47M	-$2.07M	-$1.59M	-330%	Oct 1, 2013	Dec 31, 2013	10-K	2015-03-17
Q3 2013	-$5.89M	-$1.86M	-$844K	-83%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-14
Q2 2013	-$5.04M	-$2.18M	-$1.7M	-354%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-11
Q1 2013	-$3.34M	-$1.37M	-$216K	-18.7%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-13
Q4 2012	-$3.13M	-$481K	+$830K	+63.3%	Oct 1, 2012	Dec 31, 2012	10-K	2014-03-28
Q3 2012	-$3.96M	-$1.02M	+$414K	+28.9%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-13
Q2 2012	-$4.37M	-$480K	+$993K	+67.4%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-14
Q1 2012	-$5.37M	-$1.15M	+$556K	+32.6%	Jan 1, 2012	Mar 31, 2012	10-Q/A	2013-08-19
Q4 2011	-$5.92M	-$1.31M			Oct 1, 2011	Dec 31, 2011	10-K/A	2013-08-19
Q3 2011		-$1.43M			Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-14
Q2 2011		-$1.47M			Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-14
Q1 2011		-$1.71M			Jan 1, 2011	Mar 31, 2011	10-Q/A	2012-06-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.